34 min

New COVID-19 Treatments Patients Rising Podcast

    • Medicine

Medical supply chains that transport medications for chronically ill patients are at risk of shutting down due to COVID-19. And for those that have contracted the disease, getting access to clinical trials is not an easy process. For at-risk patients, accessing life-saving medications is becoming increasingly more difficult. 
This week on the Patients Rising Podcast, we discuss treatment testing for coronavirus. We also discuss how the strain on the medical supply chain is impacting the routine medications relied on by thousands of chronically ill Americans. Finally, we follow up with some good patient news on Michael Goldsmith’s acceptance into a coronavirus clinical trial. 
Robert Hariri, M.D, Ph.D
Chairman, Founder, and CEO of Celularity
Dr. Robert Hariri is an experienced surgeon and biomedical scientist. His research focuses on utilizing stem cells for the treatment of numerous human diseases, particularly in the areas of immuno-oncology and cell therapy. Dr. Hariri’s major medical discoveries include his findings on human placenta-derived stem cells, which include pluripotent stem cells and novel immune cells. 
For nearly 14 years, Dr. Hariri served as the CEO of Celgene’s Cellular Therapeutics division, a global pharmaceutical company. In 2014, he co-founded Human Longevity, Inc., a genomics-based biotechnology company. 
Currently, Dr. Hariri serves as Chairman and CEO of Celularity. The biotech company focuses on cell therapy research based on Dr. Hariri’s findings on the uses of postpartum placenta cells. This research guides Celularity’s work in immuno-oncology and hematology. 
Dr. Hariri earned his B.A. in Biological Anthropology from Columbia University and his M.D. and Ph.D. from Cornell University. 
Hosts:
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.
Kate Pecora, Field Correspondent 
Links:
Fight Like a Warrior
Patients Rising Concierge 
Need help?
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: podcast@patientsrising.org
 
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.

Medical supply chains that transport medications for chronically ill patients are at risk of shutting down due to COVID-19. And for those that have contracted the disease, getting access to clinical trials is not an easy process. For at-risk patients, accessing life-saving medications is becoming increasingly more difficult. 
This week on the Patients Rising Podcast, we discuss treatment testing for coronavirus. We also discuss how the strain on the medical supply chain is impacting the routine medications relied on by thousands of chronically ill Americans. Finally, we follow up with some good patient news on Michael Goldsmith’s acceptance into a coronavirus clinical trial. 
Robert Hariri, M.D, Ph.D
Chairman, Founder, and CEO of Celularity
Dr. Robert Hariri is an experienced surgeon and biomedical scientist. His research focuses on utilizing stem cells for the treatment of numerous human diseases, particularly in the areas of immuno-oncology and cell therapy. Dr. Hariri’s major medical discoveries include his findings on human placenta-derived stem cells, which include pluripotent stem cells and novel immune cells. 
For nearly 14 years, Dr. Hariri served as the CEO of Celgene’s Cellular Therapeutics division, a global pharmaceutical company. In 2014, he co-founded Human Longevity, Inc., a genomics-based biotechnology company. 
Currently, Dr. Hariri serves as Chairman and CEO of Celularity. The biotech company focuses on cell therapy research based on Dr. Hariri’s findings on the uses of postpartum placenta cells. This research guides Celularity’s work in immuno-oncology and hematology. 
Dr. Hariri earned his B.A. in Biological Anthropology from Columbia University and his M.D. and Ph.D. from Cornell University. 
Hosts:
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.
Kate Pecora, Field Correspondent 
Links:
Fight Like a Warrior
Patients Rising Concierge 
Need help?
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: podcast@patientsrising.org
 
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.

34 min

Top Podcasts In Medicine